FTC supplements settlement
This article was originally published in The Tan Sheet
Gero Vita International and six related defendants are required to pay monetary judgments of $605,000 after settling Federal Trade Commission charges related to deceptive marketing practices, FTC reports June 8. The defendants, including dietary supplement direct marketer Almon Glenn Braswell, claimed their products could cure or treat illnesses and conditions such as diabetes, Alzheimer's disease and obesity, the agency says. FTC originally filed the complaint in May 2003 (1"The Tan Sheet" June 2, 2003, p. 13). The defendants are barred from making future misleading product claims in addition to the fines. The $605,000 settlement resulted from the suspension of a $30 mil. judgment based on the defendants' inability to pay. However, the defendants will have to pay the total $30 mil. if they misrepresented their financial condition or Braswell does business with any other defendant, FTC says...
You may also be interested in...
Dietary supplement direct marketer Almon Glenn Braswell and four of his corporations falsely represented New Life Nutrition magazine as an "independent publication and not paid advertising," according to an 1FTC complaint filed in Los Angeles federal court May 27
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.